Literature DB >> 33450836

Idiopathic CD4 T Cell Lymphocytopenia: A Case of Overexpression of PD-1/PDL-1 and CTLA-4.

Gaurav Kumar1,2, Heidy Schmid-Antomarchi2, Annie Schmid-Alliana2, Michel Ticchioni2, Pierre-Marie Roger2,3,4,5.   

Abstract

Idiopathic CD4 T cell lymphocytopenia (ICL) is a rare entity characterized by CD4 T cell count of <300 cells/mm3 along with opportunistic infection for which T cell marker expression remains to be fully explored. We report an ICL case for which T lymphocyte phenotype and its costimulatory molecules expression was analyzed both ex vivo and after overnight stimulation through CD3/CD28. The ICL patient was compared to five healthy controls. We observed higher expression of inhibitory molecules PD-1/PDL-1 and CTLA-4 on CD4 T cells and increased regulatory T cells in ICL, along with high activation and low proliferation of CD4 T cells. The alteration in the expression of both the costimulatory pathway and the apoptotic pathway might participate to down-regulate both CD4 T cell functions and numbers observed in ICL.

Entities:  

Keywords:  CTLA-4; Idiopathic CD4 T cell lymphocytopenia; PD-1; PDL-1; T cell; co-stimulatory molecules

Year:  2021        PMID: 33450836      PMCID: PMC7839055          DOI: 10.3390/idr13010009

Source DB:  PubMed          Journal:  Infect Dis Rep        ISSN: 2036-7430


  40 in total

1.  A closer look at homeostatic proliferation of CD4+ T cells: costimulatory requirements and role in memory formation.

Authors:  H Gudmundsdottir; L A Turka
Journal:  J Immunol       Date:  2001-10-01       Impact factor: 5.422

2.  Overexpression of Fas/CD95 and Fas-induced apoptosis in a patient with idiopathic CD4+ T lymphocytopenia.

Authors:  P M Roger; G Bernard-Pomier; E Counillon; J P Breittmayer; A Bernard; P Dellamonica
Journal:  Clin Infect Dis       Date:  1999-05       Impact factor: 9.079

Review 3.  Primary immunodeficiency diseases. Report of a WHO scientific group.

Authors: 
Journal:  Clin Exp Immunol       Date:  1997-08       Impact factor: 4.330

4.  The PDL1-PD1 axis converts human TH1 cells into regulatory T cells.

Authors:  Shoba Amarnath; Courtney W Mangus; James C M Wang; Fang Wei; Alice He; Veena Kapoor; Jason E Foley; Paul R Massey; Tania C Felizardo; James L Riley; Bruce L Levine; Carl H June; Jeffrey A Medin; Daniel H Fowler
Journal:  Sci Transl Med       Date:  2011-11-30       Impact factor: 17.956

5.  CTLA-4 and PD-1 receptors inhibit T-cell activation by distinct mechanisms.

Authors:  Richard V Parry; Jens M Chemnitz; Kenneth A Frauwirth; Anthony R Lanfranco; Inbal Braunstein; Sumire V Kobayashi; Peter S Linsley; Craig B Thompson; James L Riley
Journal:  Mol Cell Biol       Date:  2005-11       Impact factor: 4.272

6.  Blockade of programmed death-1 ligands on dendritic cells enhances T cell activation and cytokine production.

Authors:  Julia A Brown; David M Dorfman; Feng-Rong Ma; Elizabeth L Sullivan; Oliver Munoz; Clive R Wood; Edward A Greenfield; Gordon J Freeman
Journal:  J Immunol       Date:  2003-02-01       Impact factor: 5.422

7.  Update: CD4+ T-lymphocytopenia in persons without evident HIV infection--United States.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1992-08-07       Impact factor: 17.586

Review 8.  PD-1 and its ligands in tolerance and immunity.

Authors:  Mary E Keir; Manish J Butte; Gordon J Freeman; Arlene H Sharpe
Journal:  Annu Rev Immunol       Date:  2008       Impact factor: 28.527

Review 9.  Control of peripheral T-cell tolerance and autoimmunity via the CTLA-4 and PD-1 pathways.

Authors:  Brian T Fife; Jeffrey A Bluestone
Journal:  Immunol Rev       Date:  2008-08       Impact factor: 12.988

10.  B7-DC, a new dendritic cell molecule with potent costimulatory properties for T cells.

Authors:  S Y Tseng; M Otsuji; K Gorski; X Huang; J E Slansky; S I Pai; A Shalabi; T Shin; D M Pardoll; H Tsuchiya
Journal:  J Exp Med       Date:  2001-04-02       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.